The Department now offers an infusion centre for rheumatology patients receiving infliximab, tocilizumab or rituximab infusions on an outpatient basis.

The infusion centre was operational from 6th April 2009.  It is an alternative to patients going to Auckland Hospital for their infusions.

Patients receiving Rituximab, Infliximab and Tocilizumab receive their infusions in the Endocrinology Dept at Greenlane. Patients receiving Rituximab infusion for the first time generally receive their first infusion in the Immunology Day Stay Unit or in the Transition Lounge at Auckland Hospital.